intestinal obstruction

Search with Google Search with Bing
Information
Disease name
intestinal obstruction
Disease ID
DOID:8437
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT05229822 Active, not recruiting Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction March 1, 2021 December 31, 2023
NCT03773237 Active, not recruiting N/A Intralipid Versus SMOFlipid in HPN Patients December 31, 2018 September 2024
NCT00332696 Completed Phase 2 Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis September 2005 September 2008
NCT00758186 Completed Phase 3 Randomized Trial of Colonic Stents as a Bridge to Surgery October 2004 June 2008
NCT00130715 Completed N/A Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery June 1998 August 2003
NCT03663023 Completed Band Adhesions in Relation to Previous Abdominal Surgery January 1, 2006 October 31, 2011
NCT01596777 Completed Phase 1 Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects January 2010 May 2010
NCT04020939 Completed N/A The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery. March 16, 2020 March 10, 2021
NCT01899885 Completed N/A Acute High-risk Abdominal Surgery Study - an Optimized Perioperative Course June 2013 June 2015
NCT02275338 Completed Phase 2 Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction November 19, 2014 November 9, 2017
NCT03997721 Completed Pathophysiology of Perioperative Fluid Management in Emergency Laparotomy May 23, 2019 May 1, 2021
NCT01596764 Completed Phase 1 Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time. May 2011 January 2012
NCT00216372 Completed Phase 3 Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis September 2003 October 2008
NCT06245577 Recruiting N/A Biological Mesh Versus Synthetic Mesh in Interdisciplinary RRP With SCP January 30, 2024 May 31, 2026
NCT06072976 Recruiting N/A The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies June 9, 2023 June 9, 2025
NCT01196494 Terminated N/A Study of Intraoperative Colonic Irrigation Versus Stent Placement in Obstructive Left-Sided Colonic Cancer
NCT02365584 Terminated Phase 2 Quality of Life in Patients With Inoperable Malignant Bowel Obstruction January 2015 January 16, 2018
NCT04213976 Unknown status Ostomy in Continuity or Conventional Ileostomy: a Retrospective Multicentric Analysis January 1, 2020 December 31, 2020
NCT04403425 Unknown status Tissue Perfusion During Emergency Laparotomy December 25, 2020 November 30, 2022
NCT05208489 Unknown status Direct Peritoneal Resuscitation for Intra-abdominal Catastrophes December 16, 2021 June 2023
NCT01125280 Unknown status N/A Prospective Multicenter Validation of a Severity Score of Strangulated Small Bowel Occlusion July 2010 July 2013
NCT05117645 Unknown status Role of Computed Tomography in Evaluation of Different Causes of Intestinal Obstruction Correlated With Operative Findings December 2021 June 2022
NCT01669044 Unknown status Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical Patients May 2012 December 2012
NCT02928458 Withdrawn N/A Clinical and Financial Impact of an Evidenced-Based Adhesive Small Bowel Obstruction Management Protocol September 1, 2015 September 13, 2017
Disase is a (Disease Ontology)
DOID:5295
Cross Reference ID (Disease Ontology)
ICD10CM:K56.609
Cross Reference ID (Disease Ontology)
ICD9CM:560.9
Cross Reference ID (Disease Ontology)
MESH:D007415
Cross Reference ID (Disease Ontology)
NCI:C9175
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:81060008
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0021843
HPO alt_id (Human Phenotype Ontology)
HP:0005239
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0005214
MedGen concept unique identifier (MedGen Concept name)
C0021843
MedGen unique identifier (MedGen Concept name)
43933
MeSH unique ID (MeSH (Medical Subject Headings))
D007415